SRB-VAD-FMK [Sulforhodamine B-VAD-FMK] |
|
13472-25Tests |
AAT Bioquest |
25 Tests |
EUR 109 |
|
|
|
Description: SRB-VAD is a red fluorescent cell-permeable polycaspase inhibitor to target caspases 1, 2, 3, 6, 8, 9, or 10. |
Human IgG antibody Laboratories manufactures the invivogen tlrl-vad reagents distributed by Genprice. The Invivogen Tlrl-Vad reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact InVivoGen. Other Invivogen products are available in stock. Specificity: Invivogen Category: Tlrl-Vad
Z-VAD-FMK |
|
ApexBio |
1 mg |
EUR 44 |
|
|
|
Description: Cell-permeable, irreversible pan-caspase inhibitor |
Z-VAD-FMK |
|
ApexBio |
10 mg |
EUR 200 |
|
|
|
Description: Cell-permeable, irreversible pan-caspase inhibitor |
Z-VAD-FMK |
|
ApexBio |
25 mg |
EUR 320 |
|
|
|
Description: Cell-permeable, irreversible pan-caspase inhibitor |
Z-VAD-FMK |
|
ApexBio |
5 mg |
EUR 120 |
|
|
|
Description: Cell-permeable, irreversible pan-caspase inhibitor |
Z-VAD-FMK |
|
ApexBio |
10 mM (in 1mL DMSO) |
EUR 120 |
|
|
|
Description: Cell-permeable, irreversible pan-caspase inhibitor |
Chemicals information
Anti-mgp75-mIgG2a InvivoFit™ |
|
mgp75-mab10-1 |
InvivoGen FR |
1 mg |
EUR 353.85 |
Anti-mgp75-mIgG2a InvivoFit™ |
|
mgp75-mab10-10 |
InvivoGen FR |
10 mg |
EUR 2285.85 |
Anti-mIL-2-mIgG1e3 InvivoFit™ |
|
mil2-mab15-1 |
InvivoGen FR |
1 mg |
EUR 628.95 |
Anti-mIL-28b-mIgG1 InvivoFit™ |
|
mil28b-mab9-1 |
InvivoGen FR |
1 mg |
EUR 628.95 |
Anti-mIL-6-mIgG1e3 InvivoFit™ |
|
mil6-mab15-1 |
InvivoGen FR |
1 mg |
EUR 628.95 |
Anti-mIL-6-mIgG1e3 InvivoFit™ |
|
mil6-mab15-10 |
InvivoGen FR |
10 mg |
EUR 2285.85 |
Anti-mPD-1-mIgG1e3 InvivoFit™ |
|
mpd1-mab15-1 |
InvivoGen FR |
1 mg |
EUR 353.85 |
Anti-mPD-1-mIgG1e3 InvivoFit™ |
|
mpd1-mab15-10 |
InvivoGen FR |
10 mg |
EUR 2285.85 |
Anti-mPD-1-mIgG1e3 InvivoFit™ |
|
mpd1-mab15-50 |
InvivoGen FR |
50 mg |
EUR 5208 |
Anti-PD-L1-mIgG1e3 InvivoFit™ |
|
pdl1-mab15-1 |
InvivoGen FR |
1 mg |
EUR 353.85 |
Anti-PD-L1-mIgG1e3 InvivoFit™ |
|
pdl1-mab15-10 |
InvivoGen FR |
10 mg |
EUR 2285.85 |
Anti-PD-L1-mIgG1e3 InvivoFit™ |
|
pdl1-mab15-50 |
InvivoGen FR |
50 mg |
EUR 5208 |
Anti-mCTLA4-mIgG2a InvivoFit™ |
|
mctla4-mab10-1 |
InvivoGen FR |
1 mg |
EUR 353.85 |
Anti-mCTLA4-mIgG2a InvivoFit™ |
|
mctla4-mab10-10 |
InvivoGen FR |
10 mg |
EUR 2285.85 |
Anti-mCTLA4-mIgG2a InvivoFit™ |
|
mctla4-mab10-50 |
InvivoGen FR |
50 mg |
EUR 5208 |
Anti-mIL-16-mIgG1e3 InvivoFit™ |
|
mil16-mab15-1 |
InvivoGen FR |
1 mg |
EUR 628.95 |
Anti-mTIGIT-mIgG2a InvivoFit™ |
|
mtigit-mab10-1 |
InvivoGen FR |
1 mg |
EUR 353.85 |
